<!--
BASE DOCUMENT TEMPLATE — copy this header into every regulatory document.
Replace <…> placeholders. Follow SG-001 (_styleguide.md). Numbers must cite REF-002 / outputs/.
-->
<Document Title>
| Field |
Value |
| Document ID |
<TYPE-NNN> |
| Version |
<0.x draft / 1.0 final> |
| Status |
<Draft / Final> |
| Effective Date |
<YYYY-MM-DD> |
| Compound |
GLPI-103 (GLP-1/APJ dual agonist) |
| Study No. |
<GLPI103-NNN — if study-specific> |
| Sponsor |
Virtual Biopharma Inc. |
| Standard(s) |
<ICH E3 / E6(R3) / E9(R1) / M4 …> |
| Confidentiality |
Confidential — portfolio use |
Change History
| Version |
Date |
Author |
Summary of Change |
| 0.1 |
<YYYY-MM-DD> |
<author> |
Initial draft |
Abbreviations
<!-- BODY START — ICH 표준 섹션 순서대로. 모든 수치는 outputs/ 또는 REF-002 인용. -->